Institute Group Leaders awarded promotions by the University
We are delighted to announce that several of our Group Leaders have been promoted in the University of Cambridge Senior Academic Promotions.
James Brenton, Sarah Bohndiek and Doug Winton have been promoted to Professors, while Florian Markowetz and Nitzan Rosenfeld have been promoted to Directors of Research. All promotions will take effect from 1 October 2020.
James Brenton
Dr James Brenton has been promoted to Professor of Ovarian Cancer Medicine in the Department of Oncology. Brenton’s research focuses on understanding the molecular complexity of ovarian cancer to improve treatment and patient outcome.
Sarah Bohndiek
Dr Sarah Bohndiek has been promoted to Professor of Biomedical Physics in the Department of Physics. Her group focuses on developing novel imaging approaches that can be applied to understand the role of the tumour microenvironment in cancer progression.
Doug Winton
Dr Doug Winton has been promoted to Professor of Epithelial Biology in the Department of Oncology. His team investigates the cancer cells in the intestinal epithelium to understand the probability of their survival and expansion at each stage and how this varies with different mutations.
Florian Markowetz
Dr Florian Markowetz has been promoted to Director of Research. His team develops computational methods to link genomic profiles with quantitative measures of phenotypes, leading towards a comprehensive systems genetics understanding of cancer.
Nitzan Rosenfeld
Dr Nitzan Rosenfeld has been promoted to Director of Research. Nitzan’s expertise is in liquid biopsy and translational cancer research. His research group has established applications of circulating tumour DNA (ctDNA) sequencing to analyze ctDNA from blood samples of cancer patients.
Related News
See all news-
Dr Guiping Wang appointed as a Junior Group Leader
18th May 2026
Dr Guiping Wang joins the Cancer Research UK Cambridge Institute as a Junior Group Leader, starting in September 2026.
Find out more -
Shankar Balasubramanian receives the Princess of Asturias Award for Scientific and Technical Research
14th May 2026
The 2026 award recognises Prof Balasubramanian and his co-recipients David Klenerman and Pascal Meyer for their pioneering work in genome sequencing technologies.
Find out more -
Prof Sir Steve Jackson receives the 2026 Galen Medal in Therapeutics
14th May 2026
This award comes in recognition of his transformational work on the mechanisms of DNA repair, cell survival and the DNA-damage response (DDR), as well as for the development of the cancer-targeting drug Olaparib.
Find out more